I. Valtingojer

Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine

E. Barry, O. Venier, V. Simov, 2021, Cells.

YAP1 is essential for malignant mesothelioma tumor maintenance

C. Dib, L. Debussche, J. Moll, 2022, BMC cancer.

TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC

L. Debussche, S. Sidhu, J. Moll, 2023, Pharmaceuticals.

Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts

D. Lötsch, D. Surdez, J. Stampfl, 2023, NPJ precision oncology.